News

Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.

The Netherlands: ‘Boston by the North Sea?’

Candel completes Phase 3 enrollment for CAN-2409 in prostate cancer

https://www.biospace.com/article/releases/candel-therapeutics-completes-enrollment-in-phase-3-clinical-trial-of-can-2409-in-combination-with-valacyclovir-for-the-treatment-of-intermediate-high-risk-…

Funding secured to advance better medicines for patients

A message to the Candel Therapeutics team and stakeholders

Watch this short video featuring Dr. Paul-Peter Tak, as he expresses heartfelt gratitude to the dedicated team at Candel Therapeutics. In this video, Dr. Tak extends his appreciation to the invaluab…

Paul Peter Tak named to PharmaVoice’s 100 List

Pharma Voice’s 100 list is a prestigious compilation that recognizes influential leaders and innovators in the pharmaceutical and life sciences industry. Among the distinguished individuals acknowle…